About 12 results found for searched term "CD31" (0.12 seconds)
Cat.No. | Name | Target |
---|---|---|
M6572 | CD 2314 | Others |
CD 2314 is a selective RARβ agonist. | ||
M14592 | CDDO-EA | Keap1-Nrf2 |
CDDO ethyl amide; TP319; RTA 405 | ||
CDDO-EA is an NF-E2 related factor 2/antioxidant response element (Nrf2/ARE) activator. | ||
M50412 | CD31 | Others |
CD31 (PECAM-1) is platelet endothelial cell adhesion molecule-1, serves as the endothelial cell-specific receptor of clostridium perfringens b-Toxin (CPB). | ||
M55348 | 5-(chloromethyl)-3-(4-methoxyphenyl)-1,2,4-oxadiazole | Screening Compounds and Building Blocks |
5-Chloromethyl-3-(4-methoxyphenyl)-[1,2,4]oxadiazole | ||
5-(chloromethyl)-3-(4-methoxyphenyl)-1,2,4-oxadiazole | ||
M14807 | Cibinetide | Peptides |
ARA290 | ||
Cibinetide (ARA290) is an EPO-derivative, acting as a specific agonist of erythropoietin/CD131 heteroreceptor, and used for the research of neurological disease. | ||
M21677 | Recombinant Human Follistatin 288 (HEK293, C-6His) | Cytokines and Growth Factors |
FST; follistatin isoform FST317 | ||
Follistatin 288 is a secreted glycoprotein that was first identified as a follicle-stimulating hormone inhibiting substance in ovarian follicular fluid . Human follistatin 288 cDNA encodes a 317 amino acid (aa) protein with a 29 aa signal sequence, and a 288 aa mature region. Recombinant Human Follistatin/FST is produced by Mammalian expression system and the target gene encoding Gly30-Asn317 is expressed with a 6His tag at the C-terminus. | ||
M25365 | ATG-031 | Others |
ATG-031 is a humanised anti-CD24 monoclonal antibody. ATG-031 effectively stimulates macrophage-mediated phagocytosis and induces cancer cell destruction by blocking the "don't eat me" signals that characterize the growth of many cancers. ATG-031 can be used in the study of haematological malignancies as well as solid tumours. | ||
M31200 | CK7 | CDK |
CK-7 | ||
CK7 is a Cdk2/9 inhibitor, which can be used for the synthesis of Nek1 inhibitor BSc5231 and BSc5367. | ||
M41376 | DRI-C21041 | TNF Receptor |
DRI-C21041 is a CD40/CD40L interaction inhibitor, with an IC50 of 0.31 μM. | ||
M45310 | SR-1277 | Casein Kinase |
SR-1277 is a potent, selective and ATP-competitive CK1δ/ε inhibitor with IC50 values of 49 nM and 260 nM, respectively.In addition, SR-1277 inhibits FLT3, CDK4/cyclin D1, CDK6/cyclin D3, and CDK9/cyclin K with IC50 values of 305 nM, 1340 nM, 311 nM, and 109 nM, respectively. 1340 nM, 311 nM and 109 nM, respectively, and can be used in cancer research. | ||
M54033 | P8RI | Others |
P8RI (D-P8RI) is a biomimetic peptide of CD31 and a CD31 agonist. | ||
M54707 | INX-315 | CDK |
INX-315 is an orally potent and selective CDK2 inhibitor that induces cell cycle arrest in G1 phase. INX-315 also induces CDK2 substrate phosphorylation and inhibits tumor growth in a dose-dependent manner in a xenograft mouse model.INX-315 can be used in cancer-related studies. |
Products are for research use only. Not for human use. We do not sell to patients.
© Copyright 2010-2024 AbMole BioScience. All Rights Reserved.